Sqi Diagnostics Stock Beta

SQIDFDelisted Stock  USD 0.01  0.00  0.00%   
SQI Diagnostics fundamentals help investors to digest information that contributes to SQI Diagnostics' financial success or failures. It also enables traders to predict the movement of SQI Pink Sheet. The fundamental analysis module provides a way to measure SQI Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SQI Diagnostics pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

SQI Diagnostics Company Beta Analysis

SQI Diagnostics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current SQI Diagnostics Beta

    
  -0.0648  
Most of SQI Diagnostics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, SQI Diagnostics has a Beta of -0.0648. This is 107.53% lower than that of the Health Care Equipment & Supplies sector and 104.5% lower than that of the Health Care industry. The beta for all United States stocks is 56.8% lower than that of the firm.

SQI Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SQI Diagnostics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SQI Diagnostics could also be used in its relative valuation, which is a method of valuing SQI Diagnostics by comparing valuation metrics of similar companies.
SQI Diagnostics is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning SQI Diagnostics are expected to decrease at a much lower rate. During the bear market, SQI Diagnostics is likely to outperform the market.

SQI Fundamentals

About SQI Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze SQI Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SQI Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SQI Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in SQI Pink Sheet

If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes